Literature DB >> 29184469

Transanal Total Mesorectal Excision: Why, When, and How.

Marta Penna1, Christopher Cunningham1, Roel Hompes2.   

Abstract

Transanal total mesorectal excision (taTME) has evolved over the past decade fueled by advances in minimally invasive surgery. The technique aims to overcome the constraints posed by a narrow rigid pelvis and poor TME visualization that are encountered during "top-down" rectal surgery. A more accurate pelvic dissection should subsequently result in safer oncological resections and better preservation of pelvic autonomic nerves. taTME is an advanced complex technique that requires dedicated training and experience in TME surgery. Initial results from small cohorts are promising and confirmation by randomized controlled trials is eagerly awaited.

Keywords:  bottom-up; rectal cancer; total mesorectal excision; transanal

Year:  2017        PMID: 29184469      PMCID: PMC5703657          DOI: 10.1055/s-0037-1606111

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  36 in total

1.  ASGE/SAGES Working Group on Natural Orifice Translumenal Endoscopic Surgery. October 2005.

Authors:  D Rattner; A Kalloo
Journal:  Surg Endosc       Date:  2006-02       Impact factor: 4.584

2.  Stereotactic navigation and augmented reality for transanal total mesorectal excision?

Authors:  N C Buchs; R Hompes
Journal:  Colorectal Dis       Date:  2015-09       Impact factor: 3.788

3.  A new approach to rectal cancer.

Authors:  R J Heald
Journal:  Br J Hosp Med       Date:  1979-09

Review 4.  Maximizing rectal cancer results: TEM and TATA techniques to expand sphincter preservation.

Authors:  John H Marks; Joseph L Frenkel; Anthony P D'Andrea; Chistopher E Greenleaf
Journal:  Surg Oncol Clin N Am       Date:  2011-07       Impact factor: 3.495

5.  CT/MRI pelvimetry as a useful tool when selecting patients with rectal cancer for transanal total mesorectal excision.

Authors:  Alexander Ferko; Ondřej Malý; Július Örhalmi; Josef Dolejš
Journal:  Surg Endosc       Date:  2015-06-27       Impact factor: 4.584

6.  Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.

Authors:  R J Heald; B J Moran; R D Ryall; R Sexton; J K MacFarlane
Journal:  Arch Surg       Date:  1998-08

7.  Robotic-assisted laparoscopic transanal total mesorectal excision for rectal cancer: a prospective pilot study.

Authors:  Marcos Gómez Ruiz; Ignacio Martín Parra; Carlos Manuel Palazuelos; Joaquin Alonso Martín; Carmen Cagigas Fernández; Julio Castillo Diego; Manuel Gómez Fleitas
Journal:  Dis Colon Rectum       Date:  2015-01       Impact factor: 4.585

8.  No-scar transanal total mesorectal excision: the last step to pure NOTES for colorectal surgery.

Authors:  Joël Leroy; Brian Donncha Barry; Armando Melani; Didier Mutter; Jacques Marescaux
Journal:  JAMA Surg       Date:  2013-03       Impact factor: 14.766

9.  Risk factors of circumferential resection margin involvement in the patients with extraperitoneal rectal cancer.

Authors:  Sung Jin Oh; Jin Yong Shin
Journal:  J Korean Surg Soc       Date:  2012-02-27

10.  COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer.

Authors:  Charlotte L Deijen; Simone Velthuis; Alice Tsai; Stella Mavroveli; Elly S M de Lange-de Klerk; Colin Sietses; Jurriaan B Tuynman; Antonio M Lacy; George B Hanna; H Jaap Bonjer
Journal:  Surg Endosc       Date:  2015-11-04       Impact factor: 4.584

View more
  10 in total

1.  Transanal total mesorectal excision (taTME) in a single-surgeon setting: refinements of the technique during the learning phase.

Authors:  A Caycedo-Marulanda; G Ma; H Y Jiang
Journal:  Tech Coloproctol       Date:  2018-06-28       Impact factor: 3.781

Review 2.  Learning Transanal Total Mesorectal Excision.

Authors:  Elisabeth C McLemore; Peyman Lavi; Vikram Attaluri
Journal:  Clin Colon Rectal Surg       Date:  2020-04-28

Review 3.  Transanal Total Mesorectal Excision: Description of the Technique.

Authors:  Jean-Sébastien Trépanier; F Borja de Lacy; Antonio M Lacy
Journal:  Clin Colon Rectal Surg       Date:  2020-04-28

4.  Development and evaluation of a virtual knowledge assessment tool for transanal total mesorectal excision.

Authors:  Hamzeh Naghawi; Johnny Chau; Amin Madani; Pepa Kaneva; John Monson; Carmen Mueller; Lawrence Lee
Journal:  Tech Coloproctol       Date:  2022-05-03       Impact factor: 3.699

5.  Short- and long-term outcomes of transanal versus laparoscopic total mesorectal excision for mid-to-low rectal cancer: a meta-analysis.

Authors:  Xuan Zhang; Yi Gao; XingLong Dai; HongTao Zhang; ZhongJun Shang; XinYi Cai; Tao Shen; XianShuo Cheng; Kun Yu; YunFeng Li
Journal:  Surg Endosc       Date:  2018-10-29       Impact factor: 4.584

Review 6.  Critical and Challenging Issues in the Surgical Management of Low-Lying Rectal Cancer.

Authors:  Aeris Jane D Nacion; Youn Young Park; Seung Yoon Yang; Nam Kyu Kim
Journal:  Yonsei Med J       Date:  2018-08       Impact factor: 2.759

7.  Anatomy of the smooth muscle structure in the female anorectal anterior wall: convergence and anterior extension of the internal anal sphincter and longitudinal muscle.

Authors:  S Muro; Y Tsukada; M Harada; M Ito; K Akita
Journal:  Colorectal Dis       Date:  2019-01-24       Impact factor: 3.788

8.  Anal function and quality of life analysis after laparoscopic modified Parks for ultra-low rectal cancer patients.

Authors:  Haibo Ding; Jian Li; Yuxiang Chen; Zhi Yang; Zha Peng; Xin Liao
Journal:  World J Surg Oncol       Date:  2020-02-03       Impact factor: 2.754

9.  Transanal versus conventional total mesorectal excision for rectal cancer using the IDEAL framework for implementation.

Authors:  R L Robertson; A Karimuddin; T Phang; M Raval; C Brown
Journal:  BJS Open       Date:  2021-03-05

10.  An MRI-based pelvimetry nomogram for predicting surgical difficulty of transabdominal resection in patients with middle and low rectal cancer.

Authors:  Yuan Yuan; Dafeng Tong; Minglu Liu; Haidi Lu; Fu Shen; Xiaohui Shi
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.